BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023

  United Therapeutics Corporation, announced that it will report its second quarter 2023 financial results before the market opens on Wednesday, August 2, 2023.

  July 26, 2023

   · 

  2 min read
• Business

  AC Immune SA Appoints New Chief Medical Officer

  AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, announced the appointment of Nuno Mendonça, MD.

  July 26, 2023

   · 

  5 min read
• Business

  LivaNova Reports Second-Quarter 2023 Results

  LivaNova PLC, a market-leading medical technology company, reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance.

  July 26, 2023

   · 

  31 min read
• BioCapital

  AsclepiX Therapeutics Raises $10 Million to Advance Phase 1/2a Clinical Study of AXT107Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet AMD)

  AsclepiX Therapeutics, Inc., a clinical-stage biotech company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved treatments of retinal diseases, announced today that it has secured a $10 million Series A-3 financing.

  July 26, 2023

   · 

  2 min read
• CordenPharma Establishes World-Class Technology & Science Advisory Board of Experts Across Six Technology Platforms

  CordenPharma has created a new Technology & Science Advisory Board with eight world-class experts from academia and industry, who will provide strategic guidance and scientific expertise to drive forward the company’s continued growth and innovation.

  July 26, 2023

   · 

  4 min read
• Business

  EyePoint Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 2, 2023

  EyePoint Pharmaceuticals, Inc. today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, August 2, 2023 to report its second quarter 2023 financial results and highlight recent corporate developments.

  July 26, 2023

   · 

  1 min read
• Business

  CytoSorbents to Report Second Quarter 2023 Operating and Financial Results

  CytoSorbents Corporation will report second quarter 2023 operating and financial results after the market close on Tuesday, August 1st, 2023.

  July 26, 2023

   · 

  5 min read
• Business

  Alkermes plc Reports Second Quarter 2023 Financial Results

  Alkermes plc (Nasdaq: ALKS) today reported financial results for the second quarter of 2023.

  July 26, 2023

   · 

  18 min read
• Business

  REGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlights

  REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, August 2, 2023 , at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2023 , and recent operational highlights.

  July 26, 2023

   · 

  1 min read
• IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

  IMV Inc. (the “ Company ” or “ IMV ”), recently announced an update on the Sales and Investment Solicitation Process (the “ SISP ”) implemented as part of its ongoing proceedings under the Companies’ Creditors Arrangement Act (the “ CCAA ”).

  July 26, 2023

   · 

  6 min read